If approved, the targeted IGF-1 fusion protein would become the only treatment available for late-window stroke patients ...
Key Highlights Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up ...
Financing supports execution of Phase 2b RAISE trial evaluating BB-031, an investigational reversible thrombolytic for acute ...
General anesthesia leads to better functional outcomes than conscious sedation in stroke patients with large vessel occlusion ...
Baptist Health Corbin has been honored with the 2025 Stroke Gold Plus and Rural Stroke Gold awards from the American Heart ...
LOS ANGELES -- The HOPE trial made another case for extending the therapeutic window for IV thrombolysis in acute ischemic stroke, potentially widening the pool of people eligible for therapy. Among ...
The addition of levodopa doesn’t improve motor function among patients receiving inpatient rehabilitation therapy after an acute stroke, according to the results of the placebo-controlled ESTREL trial ...
"The Rocky Horror Picture Show" star told crowds at a celebration of the film's 50th anniversary Sept. 26 that he still struggles with mobility. The audience at the event, held at the Academy Museum ...
Stroke is no longer an old person’s disease — rates are climbing fastest among adults in their 20s to 40s, reshaping one of ...
This article argues that increasing headcount often ruins profitable companies, advocating for solopreneurship powered by AI and automation like ChatGPT. It suggests scaling businesses by mapping ...